ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1469

Risk Factors for Herpes Zoster Among Patients with Systemic Lupus Erythematosus

Caroline Spitznagel, Fedelis Mutiso, Jim Oates and Diane Kamen, Medical University of South Carolina, Charleston, SC

Meeting: ACR Convergence 2022

Keywords: Disparities, Infection, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) have a higher prevalence and incidence of herpes zoster (HZ) compared with the general population. Our study was to determine the current burden of HZ and describe risk factors for its development among patients with SLE.

Methods: Data was obtained from an ongoing IRB-approved longitudinal registry of patients with SLE and non-SLE controls at the Medical University of South Carolina, including demographics, medical history, and SLE-related damage (SLICC Damage Index). Patient-reported history of HZ was confirmed by electronic medical record review. Descriptive analyses, Pearson’s chi-squared testing, two-sample t-tests, and multivariable logistic regression were performed as appropriate.

Results: The study population included 726 registry participants with SLE, of whom 656 (90.36%) were female, 541 (74.52%) were Black, and 21 (2.89%) were Hispanic. In our study population, 143 (19.70%) SLE patients reported a history of HZ and 583 (80.30%) had no known history of HZ. Mean age of onset of SLE was similar between patients with and without a history of HZ, with mean ages 31.71 (+/- 14.23) and 31.17 (+/- 13.94) respectively (Table 1). Chi-square analysis revealed patients with a history of zoster were more likely to have any disease damage from SLE (SLICC-DI > 0) compared with patients who did not have a history of zoster (75.53% vs. 59.01%, p-value < 0.01). Patients with a history of zoster were also more likely to have high disease damage (SLICC-DI > 1) (54.93% vs 38.42%, p-value < 0.01). Female gender was also associated with HZ risk (95.10% vs 89.19%, p-value 0.03). There was no significant difference between HZ rates in Black vs. Non-Black patients (71.33% vs. 75.30%, p-value 0.31) or Hispanic vs. Non-Hispanic patients (2.80% vs 2.92%, p-value 0.94). We did not see a significant association between HZ and the individual SLE classification criteria (Table 2). Using logistic regression modeling, the odds of having a history of HZ with any SLE damage, adjusting for current age, gender, and race finds a significant odds ratio of 2.03 (p-value < 0.01, 95% CI 1.32-3.11).

Conclusion: Despite a lower risk of HZ among Blacks in the general population, our study found similar HZ prevalence between Blacks and non-Blacks. Additionally, our study found a significant relationship between higher SLE disease damage and HZ, consistent with findings in other SLE cohorts. Our results emphasize the need to identify HZ early among patients with dark skin, and promote HZ vaccination among those at highest risk.

Supporting image 1

Table 1: Demographic information

Supporting image 2

Table 2: Clinical characteristics


Disclosures: C. Spitznagel, None; F. Mutiso, None; J. Oates, None; D. Kamen, None.

To cite this abstract in AMA style:

Spitznagel C, Mutiso F, Oates J, Kamen D. Risk Factors for Herpes Zoster Among Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/risk-factors-for-herpes-zoster-among-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-factors-for-herpes-zoster-among-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology